Management of head and neck cancer of unknown primary: A phase IV study by DAHANCA

Head and Neck Cancer

Multidisciplinary evidence-based consensus statements on salvage surgery for recurrent head and neck cancer (International Centre for Recurrent head and neck Cancer)

J Natl Cancer Inst

Williamson A, Brady G, Harris N, Haris PA, Bisase B, Chiu K, Douglas C, Fleming J, Hamilton D, Haridass A, Hughes C, Iqbal MS, Kerawala C, King E, Liu Z, McCaul J, Montgomery J, Nankivell P, Nixon I, Noble D, Nugent M, Paterson C, Pracy P, Riva F, Roe J, Schache A, Selbong U, Schilling C, Simo R, Winter S, O'Leary B, Paleri V

doi: 10.1093/jnci/djaf128

Further Publications

Impact of edoxaban-related adverse events in patients with cancer experiencing venous thromboembolism during antineoplastic therapy: Results of the phase IV EDOI study (GOIRC-05-2018)

Eur J Cancer

Maglietta G, Damato A, Finotto S, Mandarà M, Tamberi S, Grisanti S, Brighenti M, Tiseo M, Montesarchio V, Catino A, Gelsomino F, Giovanardi F, Antonuzzo L, Romagnani A, Gervasi E, Di Maio M, Pinto C

doi: 10.1016/j.ejca.2025.115296

SPECIAL REPORT

Breast Cancer

Advances in HER2-Negative Breast Cancer Treatment: Insights from the PRIMED study

Head and Neck Cancer

Trends and efficacy of definitive radiotherapy regimens for locally advanced head and neck cancer in elderly patients: A population-based analysis by the German cancer registry group

Eur J Cancer

Tinhofer I, Hofmann E, Trelinska-Finger A, Saraei T, Keilholz U, Heiland M, Letsch A, Knödler M, Beck M, Klinghammer K, Dommerich S, Wittenberg I, Reinwald F, Sackmann A, Klinkhammer-Schalke M, Zeissig SR, Weitmann K, Franke B, Schneider C, Zips D, Doll C

doi: 10.1016/j.ejca.2025.116039

Further Publications

Molecularly directed therapy in cancers of unknown primary: A systematic review and meta-analysis

Eur J Cancer

Labaki C, Eid M, Bakouny Z, Hobeika C, Chehade REH, Chebel R, Boussios S, Anthony Greco F, Pavlidis N, Rassy E

doi: 10.1016/j.ejca.2025.115447

Gynecologic Cancer

Neoadjuvant chemotherapy followed by interval surgery versus primary debulking surgery in FIGO stage III-IV epithelial ovarian cancer: A systematic review and meta-analysis

Eur J Cancer

Secchi M, Signorelli M, Rulli E, Maruccio M, Di Martino G, Spadaro D, Giudice E, Turinetto M, Landoni F, Restaino S, Vizzielli G, Martinelli F, Lorusso D

doi: 10.1016/j.ejca.2025.116116

SPECIAL REPORT

Breast Cancer

Managing Side Effects in Breast Cancer Treatment

Head and Neck Cancer

Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience

J Natl Cancer Inst

Sousa LG, Edward Bates J, Anand P, Caudell JJ, Colevas AD, Runge CL, Sharon JD, Awan M, Beadle BM, Choe JH, Gidley PW, Harari PM, Henson C, Katzel JA, Lee NY, Mcdowell L, Mell LK, Nader ME, Rudra S, Wang K, Yang G, Yom SS, Wise-Draper TM

doi: 10.1093/jnci/djaf343

Head and Neck Cancer

Patient-related prognostic factors in older adults with head and neck cancer: The EGeSOR clinical trial

Eur J Cancer

Lafont C, Paillaud E, Jean C, Bertolus C, Baron M, Caillet P, Bouvard E, Laurent M, Salvan D, Chaumette L, de Decker L, Piot B, Barry B, Raynaud-Simon A, Sauvaget E, Minard A, Brugel L, Canouï-Poitrine F

doi: 10.1016/j.ejca.2025.115630

Related content

Multidisciplinary evidence-based consensus statements on salvage surgery for recurrent head and neck cancer (International Centre for Recurrent head and neck Cancer)

Impact of edoxaban-related adverse events in patients with cancer experiencing venous thromboembolism during antineoplastic therapy: Results of the phase IV EDOI study (GOIRC-05-2018)

Advances in HER2-Negative Breast Cancer Treatment: Insights from the PRIMED study

Trends and efficacy of definitive radiotherapy regimens for locally advanced head and neck cancer in elderly patients: A population-based analysis by the German cancer registry group

Molecularly directed therapy in cancers of unknown primary: A systematic review and meta-analysis

Neoadjuvant chemotherapy followed by interval surgery versus primary debulking surgery in FIGO stage III-IV epithelial ovarian cancer: A systematic review and meta-analysis

Managing Side Effects in Breast Cancer Treatment

Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience

Patient-related prognostic factors in older adults with head and neck cancer: The EGeSOR clinical trial